Polish pharmaceuticals distributor Grupa Prosper says that its net profit totaled 3.8 million zloty ($1.26 million) in the first quarter of 2006, sky-rocketing 72.7% on the like, year-ago period, according to the Interfax news agency. During the reported quarter, its sales revenue grew 10% to 490.0 million zloty.
The Warsaw-headquartered company noted that its first quarter revenue growth out stripped P oland's drugs distribution market as a whole, pointing out that it controls approximately 10% of the sector.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze